Search alternatives:
"structuralism" » "structural", "structurally"

1
Published 2015
Canadian Agency for Drugs and Technologies in Health
... or the floor of the mouth. They can also spread or originate from the bony structures of the mandibles. Oral...

2
Published 2016
Canadian Agency for Drugs and Technologies in Health
... (24-hour care in a structured setting, usually for patients who are severely depressed, traumatized...

3
Published 2016
Canadian Agency for Drugs and Technologies in Health
... (24-hour care in a structured setting, usually for patients who are severely depressed, traumatized...

4
Published 2016
Canadian Agency for Drugs and Technologies in Health
...: inpatient hospitalization (i.e., 24-hour care in a structured setting, usually for patients who are severely...

5
Published 2016
Canadian Agency for Drugs and Technologies in Health
...: inpatient hospitalization (i.e., 24-hour care in a structured setting, usually for patients who are severely...

6
by Brett, Kendra
Published 2018
Canadian Agency for Drugs and Technologies in Health
...) and associated structures, and affect 5% to 12% of individuals. TMD can lead to chronic pain, tooth grinding...

7
by Brett, Kendra
Published 2018
Canadian Agency for Drugs and Technologies in Health
...) and associated structures, and affect 5% to 12% of individuals. TMD can lead to chronic pain, tooth grinding...

8
Published 2019
Canadian Agency for Drugs and Technologies in Health
... be structured for treating adults with eligible types of refractory or relapsed large B-cell lymphoma?...

9
Published 2019
Canadian Agency for Drugs and Technologies in Health
... be structured for treating adults with eligible types of refractory or relapsed large B-cell lymphoma?...

10
Published 2013
Canadian Agency for Drugs and Technologies in Health
... to detect underlying structural vascular abnormality in a non-invasive way and to predict the risk...

11
Published 2013
Canadian Agency for Drugs and Technologies in Health
... to detect underlying structural vascular abnormality in a non-invasive way and to predict the risk...

12
Published 2019
Canadian Agency for Drugs and Technologies in Health
... Canadian jurisdictions structure the provision of axicabtagene ciloleucel to adults with large B-cell...

13
Published 2019
Canadian Agency for Drugs and Technologies in Health
... Canadian jurisdictions structure the provision of axicabtagene ciloleucel to adults with large B-cell...

14
by Tran, Khai, Argáez, Charlene
Published 2017
Canadian Agency for Drugs and Technologies in Health
... proteins remaining in the interstitial space, and potential lymphatic structure damage due to high pressure...

15
Published 2021
Canadian Agency for Drugs and Technologies in Health
... was unable to address several important limitations associated with the model structure. Notably, the sponsor...

16
Published 2020
Canadian Agency for Drugs and Technologies in Health
... structural and parameter uncertainties that affect the overall precision of the cost-effectiveness estimates....

17
Published 2019
Canadian Agency for Drugs and Technologies in Health
... with mild to moderate major depressive disorder or anxiety disorders? iCBT is defined as structured...

18
by Pohar, Ron, Rabb, Danielle
Published 2018
CADTH
...The four Botulinum neurotoxin type A (BoNT-A) products have different complex protein structures...

19
Published 2019
Canadian Agency for Drugs and Technologies in Health
... with mild to moderate major depressive disorder or anxiety disorders? iCBT is defined as structured...

20
by Pohar, Ron, Rabb, Danielle
Published 2018
CADTH
...The four Botulinum neurotoxin type A (BoNT-A) products have different complex protein structures...